Skip to main content

Advertisement

SpringerLink
Log in

miR-449a Regulates Proliferation and Chemosensitivity to Cisplatin by Targeting Cyclin D1 and BCL2 in SGC7901 Cells

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Recently, several miRNAs have been determined as tumor suppressors in various cancers, such as microRNA-449a. However, the exact molecular mechanisms underlying miR-449a regulated cell proliferation and chemosensitivity in gastric cancer cells have not been well documented.

Aim

The present study was designed to test whether miR-449a mediates cell proliferation and chemosensitivity in gastric cancer cells via regulating cyclin D1 and BCL2.

Methods

In vitro, the ability of cell proliferation and cell viability were measured by MTT assay; cell cycle and cell apoptosis was detected by FCM. qRT-PCR was used to measure the expression of miR-449a. Western blot and real-time PCR assays were used to detect the expression of cyclin D1 and BCL2 in gastric cancer cell line SGC7901.

Results

miR-449a expression was downregulated in gastric cancer cell line SGC7901 and human gastric cancer tissues, compared to the gastric epithelial cell line GES-1 and matched non-tumor associated tissues. Upregulation of miR-449a reduced the proliferation of SGC7901 cells. Ectopic expression of miR-449a decreased the percentage of S phase cells, increased the percentage of G1/G0 phase cells and increased the apoptosis induced by cisplatin. Moreover, miR-449a inhibited SGC7901 cells proliferation and enhanced cisplatin chemosensitivity by downregulating expression of BCL2 and cyclin D1, respectively, via directly targeting the 3′-untranslated regions of BCL2 and cyclin D1 mRNA.

Conclusions

This is the first report to provide evidence that miR-449a could modulate cell cycle and apoptosis through regulating cyclin D1 and BCL2 expression in SGC7901 cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106–130.

    Article  PubMed  Google Scholar 

  2. Dicken BJ, Bigam DL, Cass C, et al. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg. 2005;241:27–39.

    PubMed  Google Scholar 

  3. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11–20.

    Article  CAS  PubMed  Google Scholar 

  4. Liu K, Qian T, Tang L, et al. Decreased expression of microRNA let-7i and its association with chemotherapeutic response in human gastric cancer. World J Surg Oncol. 2012;10:225.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Ambros V. The functions of animal microRNAs. Nature. 2004;431:350–355.

    Article  CAS  PubMed  Google Scholar 

  6. de Moor CH, Meijer H, Lissenden S. Mechanisms of translational control by the 3′ UTR in development and differentiation. Semin Cell Dev Biol. 2005;16:49–58.

    Article  PubMed  Google Scholar 

  7. Kovalchuk O, Filkowski J, Meservy J, et al. Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol Cancer Ther. 2008;7:2152–2159.

    Article  CAS  PubMed  Google Scholar 

  8. Boren T, Xiong Y, Hakam A, et al. MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy. Gynecol Oncol. 2009;113:249–255.

    Article  CAS  PubMed  Google Scholar 

  9. Ji Q, Hao X, Meng Y, et al. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer. 2008;8:266.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Yang N, Kaur S, Volinia S, et al. MicroRNA microarray identifies let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res. 2008;68:10307–10314.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Noonan EJ, Place RF, Pookot D, et al. miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene. 2009;28:1714–1724.

    Article  CAS  PubMed  Google Scholar 

  12. Lize M, Pilarski S, Dobbelstein M. E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis. Cell Death Differ. 2010;17:452–458.

    Article  CAS  PubMed  Google Scholar 

  13. Bou Kheir T, Futoma-Kazmierczak E, Jacobsen A, et al. miR-449 inhibits cell proliferation and is down-regulated in gastric cancer. Mol Cancer. 2011;10:29.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Capuano M, Iaffaldano L, Tinto N, et al. MicroRNA-449a overexpression, reduced NOTCH1 signals and scarce goblet cells characterize the small intestine of celiac patients. PLoS One. 2011;6:e29094.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Biliran H Jr, Wang Y, Banerjee S, et al. Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line. Clin Cancer Res Off J Am Assoc Cancer Res. 2005;11:6075–6086.

    Article  CAS  Google Scholar 

  16. Dai ZJ, Gao J, Ji ZZ, et al. Matrine induces apoptosis in gastric carcinoma cells via alteration of Fas/FasL and activation of caspase-3. J Ethnopharmacol. 2009;123:91–96.

    Article  CAS  PubMed  Google Scholar 

  17. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834–838.

    Article  CAS  PubMed  Google Scholar 

  18. Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact. J Clinical Oncol Off J Am Soc ClinOncol. 2009;27:5848–5856.

    Article  CAS  Google Scholar 

  19. Chen H, Lin YW, Mao YQ, et al. MicroRNA-449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteins. Cancer Lett. 2012;320:40–47.

    Article  CAS  PubMed  Google Scholar 

  20. Yang X, Feng M, Jiang X, et al. miR-449a and miR-449b are direct transcriptional targets of E2F1 and negatively regulate pRb-E2F1 activity through a feedback loop by targeting CDK6 and CDC25A. Genes Dev. 2009;23:2388–2393.

    Article  CAS  PubMed  Google Scholar 

  21. Fu M, Wang C, Li Z, et al. Minireview: cyclin D1: normal and abnormal functions. Endocrinology. 2004;145:5439–5447.

    Article  CAS  PubMed  Google Scholar 

  22. Schultz J, Lorenz P, Gross G, et al. MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Res. 2008;18:549–557.

    Article  CAS  PubMed  Google Scholar 

  23. Yang J, Liu X, Bhalla K, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 1997;275:1129–1132.

    Article  CAS  PubMed  Google Scholar 

  24. Xia L, Zhang D, Du R, et al. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer. 2008;123:372–379.

    Article  CAS  PubMed  Google Scholar 

  25. Zhu W, Shan X, Wang T, et al. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int J Cancer. 2010;127:2520–2529.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Digestion, The Danyang People’s Hospital, 2 Xinmin West Road, Danyang, 212300, Jiangsu, People’s Republic of China

    Jianghong Hu

  2. Department of Central Laboratory, The Fourth Affiliated People’s Hospital, Jiangsu University, 20 ZhengDong Road, Zhenjiang, 212001, Jiangsu, People’s Republic of China

    Yue Fang & Yuan Cao

  3. Department of Oncology, The Affiliated of People’s Hospital, Jiangsu University, 8 DianLi Road, Zhenjiang, 212001, Jiangsu, People’s Republic of China

    Rong Qin

  4. Department of Central Laboratory, The Affiliated People’s Hospital, Jiangsu University, 8 DianLi Road, Zhenjiang, 212001, Jiangsu, People’s Republic of China

    Qiaoyun Chen

Authors
  1. Jianghong Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yue Fang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuan Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rong Qin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Qiaoyun Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qiaoyun Chen.

Additional information

Jianghong Hu and Yue Fang contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hu, J., Fang, Y., Cao, Y. et al. miR-449a Regulates Proliferation and Chemosensitivity to Cisplatin by Targeting Cyclin D1 and BCL2 in SGC7901 Cells. Dig Dis Sci 59, 336–345 (2014). https://doi.org/10.1007/s10620-013-2923-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-013-2923-3

Keywords

Search

Navigation